Literature DB >> 21697158

18F-DOPA PET/CT unravels malignant paraganglioma mimicking temporomandibular joint disorder.

A Terzic1, M Becker, M Wissmeyer, P Scolozzi.   

Abstract

This report presents a 29-year-old patient with severe temporomandibular joint (TMJ) pain. Anamnesis and clinical examination led us to the diagnosis of TMJ disorder. He was also in control for a malignant paraganglioma originating from the right carotid body. After initial surgery 8.5 years ago and the removal of metastases 2 years ago he was deemed disease free. An (18)F-3,4-dihydroxyphenylalanine (DOPA) positron emission tomography (PET)/CT scan was obtained during follow-up 6 months before he was presented to our clinic. Suspicious of a connection between the actual pain and the tumour, we scrutinized these images. We found a tiny pathological tracer uptake in the right jugular foramen but no correlating finding in the matching CT. We repeated the DOPA PET/CT and found several metastases including the previously detected lesion. Further thin-slice CT and MRI showed a 5 mm paraganglioma located anteriorly to the jugular bulb within the jugular foramen. The lesion was in close relation to the Arnold's nerve, a branch of the vagus nerve which carries sensory information from the external tympanic membrane, external auditory canal and the external ear and explained the severe pain in our patient. He then underwent radiotherapy (45 Gy) during which the pain diminished considerably. In a variety of neuroendocrine tumours, including paraganglioma, DOPA PET/CT allows primary diagnosis, staging and restaging with a higher detection rate than conventional radiological imaging. Owing to low anatomical resolution however, high resolution contrast-enhanced CT and MRI are necessary to complete the investigations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697158      PMCID: PMC3520260          DOI: 10.1259/dmfr/22707693

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  11 in total

1.  Which paragangliomas of the head and neck have a higher rate of malignancy?

Authors:  Alessandra Rinaldo; David Myssiorek; Kenneth O Devaney; Alfio Ferlito
Journal:  Oral Oncol       Date:  2004-05       Impact factor: 5.337

2.  Differential diagnosis of jugular foramen lesions.

Authors:  Thomas J Vogl; Sotirios Bisdas
Journal:  Skull Base       Date:  2009-01

3.  Carotid body tumor with concurrent masticatory pain dysfunction.

Authors:  S L Roistacher
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1997-01

4.  National Cancer Data Base report on malignant paragangliomas of the head and neck.

Authors:  John H Lee; Frank Barich; Lucy Hynds Karnell; Robert A Robinson; Weining K Zhen; Bruce J Gantz; Henry T Hoffman
Journal:  Cancer       Date:  2002-02-01       Impact factor: 6.860

5.  18F-DOPA positron emission tomography for the detection of glomus tumours.

Authors:  Stefan Hoegerle; Nadir Ghanem; Carsten Altehoefer; Joerg Schipper; Ingo Brink; Ernst Moser; Hartmut P H Neumann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-05       Impact factor: 9.236

6.  Paragangliomas of the temporal bone: high-resolution CT studies.

Authors:  D W Chakeres; D L LaMasters
Journal:  Radiology       Date:  1984-03       Impact factor: 11.105

7.  Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.

Authors:  Henri J L M Timmers; Clara C Chen; Jorge A Carrasquillo; Millie Whatley; Alexander Ling; Bastiaan Havekes; Graeme Eisenhofer; Lucia Martiniova; Karen T Adams; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2009-10-28       Impact factor: 5.958

Review 8.  Pathologic conditions of the lower cranial nerves IX, X, XI, and XII.

Authors:  Bruno A Policeni; Wendy R K Smoker
Journal:  Neuroimaging Clin N Am       Date:  2008-05       Impact factor: 2.264

Review 9.  Paragangliomas of the head and neck.

Authors:  Phillip K Pellitteri; Alessandra Rinaldo; David Myssiorek; C Gary Jackson; Patrick J Bradley; Kenneth O Devaney; Ashok R Shaha; James L Netterville; Johannes J Manni; Alfio Ferlito
Journal:  Oral Oncol       Date:  2004-07       Impact factor: 5.337

10.  18F-FDOPA: a multiple-target molecule.

Authors:  Heikki Minn; Saila Kauhanen; Marko Seppänen; Pirjo Nuutila
Journal:  J Nucl Med       Date:  2009-11-12       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.